Advanced Clinical appoints John Cargill as CCO

22 October 2026

Chicago, USA-based clinical research organization (CRO) Advanced Clinical which is  providing full-service clinical development, functional service provider (FSP) solutions and strategic resourcing, has appointed John Cargill as chief commercial officer (CCO).

In his new role, Mr Cargill will lead Advanced Clinical’s global commercial strategy, focusing on expanding its presence across the pharmaceutical and biotechnology sectors, strengthening existing client relationships and identifying new growth opportunities across its integrated service portfolio.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Company Spotlight



More Features in Pharmaceutical